Carl Hansen

Carl Hansen is the Chief Executive Officer of AbCellera Biologics Inc., a Canada-based biotech company. He has voiced concerns that significant reductions in U.S. drug spending, as proposed by recent executive orders, could devastate the pharmaceutical industry unless other countries compensate for the loss. Hansen emphasizes the importance of high prices for successful drug development to account for the costs associated with bringing new medications to market.